Table 1.
Demographics and tumor characteristics
| Characteristic (N=14) | |||
|---|---|---|---|
| Age Group, years (%) | 18-29 | 1 | (7) |
| 30-39 | 0 | (0) | |
| 40-49 | 2 | (14) | |
| 50-59 | 9 | (64) | |
| 60-69 | 2 | (14) | |
| Age, median years (range) | 53 | (25- 66) |
|
| Race (%) | Caucasian | 12 | (85) |
| Black | 2 | (14) | |
| Weight (kg), mean (range) | 76.7 | (43- 117) |
|
| Primary Site (%) | Ovary | 9 | (64) |
| Cervix | 2 | (14) | |
| Breast | 3 | (21) | |
| GOG Performance Status (%) | 0 | 9 | (64) |
| 1 | 3 | (21) | |
| 2 | 2 | (14) | |
| Prior treatment regimens, median (range) | 6.5 | (2-16) | |
| Median doses received (range) | 12 | (0-37) | |
| Received max dose of 1.2 mg/m2, (%) | 9 | (64) | |
| Total evaluable patients | Cervix | 2 | |
| Ovary | 5 | ||
| Breast | 0 |